88
Participants
Start Date
June 5, 2009
Primary Completion Date
January 11, 2019
Study Completion Date
October 31, 2028
Stanford V Chemotherapy
The Stanford V regimen is an abbreviated, multi-agent, dose-intensive regimen that utilizes many of the most active chemotherapy agents for Hodgkin lymphoma: Vinblastine, Doxorubicin, Vincristine, Bleomycin, Mechlorethamine, Etoposide, and Prednisone
Radiation Therapy
Patients who achieve less than a complete response after 8 weeks of chemotherapy will receive 25.5 Gy to individual nodal sites (tailored fields) starting 2-3 weeks following completion of all chemotherapy and recovery of ANC to at least 1000.
St. Jude Children's Research Hospital, Memphis
Children's Hospital of Illinois at OSF St. Francis Medical Center, Peoria
Rady Children's Hospital- San Diego, San Diego
Packard Children's Hospital, Stanford University, Palo Alto
Maine Children's Cancer Program (MCCP), Scarborough
Dana-Farber Harvard Cancer Center, Boston
St. Jude Children's Research Hospital
OTHER